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Cell-to-cell heterogeneity drives a range of (patho)physiologically important phenomena,
such as cell fate and chemotherapeutic resistance. The role of metabolism, and
particularly of mitochondria, is increasingly being recognized as an important explanatory
factor in cell-to-cell heterogeneity. Most eukaryotic cells possess a population of
mitochondria, in the sense that mitochondrial DNA (mtDNA) is held in multiple copies per
cell, where the sequence of each molecule can vary. Hence, intra-cellular mitochondrial
heterogeneity is possible, which can induce inter-cellular mitochondrial heterogeneity,
and may drive aspects of cellular noise. In this review, we discuss sources of
mitochondrial heterogeneity (variations between mitochondria in the same cell, and
mitochondrial variations between supposedly identical cells) from both genetic and non-
genetic perspectives, and mitochondrial genotype-phenotype links. We discuss the
apparent homeostasis of mtDNA copy number, the observation of pervasive intra-cellular
mtDNA mutation (which is termed “microheteroplasmy”), and developments in the
understanding of inter-cellular mtDNA mutation (“macroheteroplasmy”). We point to
the relationship between mitochondrial supercomplexes, cristal structure, pH, and
cardiolipin as a potential amplifier of the mitochondrial genotype-phenotype link. We also
discuss mitochondrial membrane potential and networks as sources of mitochondrial
heterogeneity, and their influence upon the mitochondrial genome. Finally, we revisit
the idea of mitochondrial complementation as a means of dampening mitochondrial
genotype-phenotype links in light of recent experimental developments. The diverse
sources of mitochondrial heterogeneity, as well as their increasingly recognized role
in contributing to cellular heterogeneity, highlights the need for future single-cell
mitochondrial measurements in the context of cellular noise studies.
Keywords: mitochondria, microheteroplasmy, macroheteroplasmy, complementation, cellular noise,
heteroplasmy variance
1. INTRODUCTION
Cellular heterogeneity plays central functional roles in a variety of biomedically important
phenomena, such as development (Vassar et al., 1993; Chang et al., 2008), virus infection (Snijder
et al., 2009), chemotherapeutic resistance (Spencer et al., 2009; Márquez-Jurado et al., 2018), and
gene expression in aging (Bahar et al., 2006). Inter-cellular heterogeneity may arise from the
intrinsically stochastic nature of cellular processes including gene transcription (Elowitz et al., 2002;
Swain et al., 2002), but also from “extrinsic” sources such as the cell cycle (Newman et al., 2006) and
partitioning noise (Huh and Paulsson, 2011a,b; Johnston and Jones, 2015).
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We define mitochondrial heterogeneity as (1) the variation of
a mitochondrial feature within the mitochondrial population of
a single cell, and (2) the variation of a mitochondrial feature,
potentially aggregated at the per-cell level, between supposedly
identical cells. Mitochondrial heterogeneity has been found to
be an important correlate of extrinsic cellular noise. Das Neves
et al. (2010) and Johnston et al. (2012) found that mitochondrial
mass, scaled by mitochondrial membrane potential, correlates
strongly with global transcription rate at the single-cell level
(also accounting for ∼50% of the heterogeneity observed in
protein levels; Guantes et al., 2015). Since global transcription
rate has diverse implications for cellular function (Raj and van
Oudenaarden, 2008), this link provides compelling evidence for
the importance of mitochondrial heterogeneity as a contributor
to cellular noise. Indeed, mathematical modeling predicted that
mitochondrial functionality influences stem cell differentiation
(Johnston et al., 2012), which has received experimental support
(Gaál, 2014; Sukumar et al., 2016; Ansó et al., 2017). Furthermore,
mitochondrial heterogeneity has been correlated with cell-to-
cell heterogeneity in chemotherapeutic resistance in mammalian
cells (Mizutani et al., 2009; Yao et al., 2013; Márquez-Jurado
et al., 2018), as well as proliferation rate and drug resistance
in yeast (Dhar et al., 2018). While many existing studies
on mitochondrial heterogeneity are correlative, rather than
showing causal mechanisms, the importance of metabolic noise
is becoming more widely recognized, including in prokaryotic
systems (Kiviet et al., 2014; Takhaveev and Heinemann, 2018).
In this review, we discuss sources of mitochondrial
heterogeneity. Since individual cells consist of a population
of mitochondria, intra-cellular heterogeneity may exist and
may give rise to inter-cellular heterogeneity. Mitochondria also
display a rich physiology, in addition to genetic aspects. We
therefore partition our discussion into genetic and non-genetic
sources of mitochondrial heterogeneity and indicate their
inter-dependence through genotype-phenotype links (Figure 1).
Our discussion is biomedically focussed, so we will emphasize
findings in humans and model organisms used to study human
disease such as mouse, fly, worm and yeast (the plant kingdom
has several unique aspects of mitochondrial heterogeneity,
recently reviewed by Johnston, 2018). We provide a necessarily
non-exhaustive discussion of recent developments in these
topics, and point out potential areas for future development.
2. GENETIC SOURCES OF
MITOCHONDRIAL HETEROGENEITY
Genetic and non-genetic sources of mitochondrial heterogeneity
are not independent. Variation in the amount and sequence
of mtDNA affects the number and sequence of corresponding
transcripts, eventually affecting respiratory output (although
these relationships may be non-linear; Rossignol et al., 2003;
Rocher et al., 2008; Picard et al., 2014; Aryaman et al., 2017b).
Conversely, the non-genetic state of the cell may affect the
mitochondrial genetic state, for instance AMP/ATP ratios may
alter mitochondrial biogenesis and autophagy (mitophagy) rates
(Palikaras and Tavernarakis, 2014). Variation inmtDNA turnover
rates have the potential to affect not only mtDNA copy number
but also heteroplasmy (defined as the fraction of a particular
variant allele of mtDNA per cell) through neutral genetic drift
(Birky et al., 1983; Chinnery and Samuels, 1999; Capps et al.,
2003; Wonnapinij et al., 2008; Johnston and Jones, 2016), and
selective effects (Larsson et al., 1990; Hart et al., 1996; Bua et al.,
2006; Ye et al., 2014; Li et al., 2015; Morris et al., 2017; Floros
et al., 2018), as we discuss below.
2.1. Inter-cellular MtDNA Copy Number
Appears to Be Under Homeostatic Control
2.1.1. MtDNA Copy Number Appears to Be Under
Homeostatic Control
A potential source of mitochondrial genotypic heterogeneity is
simply the quantity of mtDNA per cell. A proliferating cell is
expected to increase its complement of mtDNAs by a factor
of 2 over the cell cycle, and noisily partition those molecules
upon division (Johnston and Jones, 2015) (Figure 1Ai). However,
a number of studies suggest that cytoplasmic mtDNA density
is tightly controlled within a variety of replicating cell types
(although mtDNA copy number, and density, varies radically
between different cell types; Wilson et al., 2001). Work in
HeLa cells (Posakony et al., 1977) and budding yeast (Rafelski
et al., 2012) have indicated that mitochondrial volume increases
approximately in proportion to cytoplasmic volume, although we
note that a recent in vivo study involving hypertrophic mouse
hepatocytes suggested that mtDNA density may reduce with
cell size (Miettinen et al., 2014). Further single-cell studies are
required to validate this observation. Studies in proliferative
human cell lines (Iborra et al., 2004; Tauber et al., 2013), budding
yeast (Osman et al., 2015) and fission yeast (Jajoo et al., 2016)
have shown that the distribution of inter-nucleoid spacings is
significantly perturbed from random, suggesting that mtDNA
density is controlled in proliferating cells. Indeed, mathematical
modeling using a constant mitochondrial density (Johnston et al.,
2012) was able to explain a range of single-cell data for replicating
cells (Das Neves et al., 2010).
2.1.2. Interpretation of Apparent mtDNA Copy
Number Homeostasis
The conservation of mitochondrial density is somewhat
surprising, given that mitochondrial density is a potential axis
for cells to control power production in response to differing
demands, especially in the context of differing cell volume.
Smaller cells have a larger surface area to volume ratio, therefore
power demand is not expected to scale linearly with cell volume.
Mathematical modeling has suggested that cells may instead
modulate their mitochondrial membrane potential, rather than
their mtDNA density, to satisfy cellular demands in mammalian
cells (Miettinen and Björklund, 2016; Aryaman et al., 2017a),
perhaps affording the cell more control sincemembrane potential
may change on a faster timescale than mtDNA biogenesis. The
extent to whichmtDNA density homeostasis holds in the absence
of cell volume variation driven by the cell cycle, i.e., quiescent
cells, has yet to be carefully explored (Figure 1Ai) despite its
relevance for mosaic dysfunction in aging post-mitotic tissues
(Kauppila et al., 2017).
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FIGURE 1 | Sources of mitochondrial heterogeneity from genetic and non-genetic mitochondrial sources. (A) Potential sources of mitochondrial genetic
heterogeneity. (i) A proliferative cell which doubles in volume is expected to replicate its mtDNA complement by approximately ×2 to avoid dilution, which may
confound measurements of copy number heterogeneity; noise at partitioning is thought to be somewhat suppressed. The extent of copy number heterogeneity in
quiescent cells, and its consequences, are not fully understood. (ii) A cloud of mutations around the consensus sequence is expected given a finite mtDNA mutation
rate; we term this “microheteroplasmy.” The actual mutant proportion for most mutations is expected to be very small in reality. (iii) In the more canonical case,
“macroheteroplasmy,” a deleterious sequence (such as a deleterious single nucleotide polymorphism or deletion, red circles) induces a pathological phenotype above
a threshold heteroplasmy. By contrast, intermediate heteroplasmy has been observed to induce large fitness disadvantages but homoplasmy does not, indicating
discord between the two alleles. (B) Potential sources of mitochondrial non-genetic heterogeneity. (i) MtDNA sequence variation can induce variation in the structure of
corresponding proteins. (ii) Cristal structure is variable and physiologically regulated to control respiratory output. (iii) A landscape of different supercomplex
stoichiometries exists. (iv) Spatially-restricted, transient, depolarization/repolarization cycles of the mitochondrial network are observed. (v) The extent of mitochondrial
fragmentation influences heteroplasmy dynamics (see Equation 1). (vi) Intercellular heterogeneity in mitochondrial membrane potential has been shown to be an
important source of cellular noise. (vii) Potential sources of mitochondrial epigenetic heterogeneity. MtDNA is observed to undergo epigenetic modification by
methylation, although the physiological significance of this is uncertain. Also, oxidative damage to mtDNA nucleotides may cause transcriptional errors. (viii) There are
numerous other sources of non-genetic heterogeneity: from distinct spatial niches to ER-mitochondrial interactions. For further discussion, see Main Text.
2.1.3. Pathological Consequences of Loss of mtDNA
Copy Number Homeostasis
In humans, a variety of nuclearmutations which induce defects in
mtDNAmaintenance cause mitochondrial depletion syndromes;
these are severe disorders and clinically diverse in their
physiological impact (El-Hattab and Scaglia, 2013). Conversely,
it has been shown that increasing mtDNA copy number can
rescue male infertility in mice engineered to accumulate mtDNA
mutations, despite unaltered heteroplasmy (Trifunovic et al.,
2004; Jiang et al., 2017). It has been hypothesized that failure
to maintain homeostasis in the density of functional mtDNAs
may underlie the pathology of one of the most common mtDNA
mutations associated with mitochondrial disease (3243A>G
tRNA mutation) (Aryaman et al., 2017b). A mathematical
model of human cybrid cells with the 3243A>G mutation was
consistent with a range of omics data (Picard et al., 2014), made
by assuming that cells attempt to maintain mtDNA density
homeostasis through cytoplasmic volume reduction, until a
minimum cell volume is reached where cells undergo a switch
in their metabolic response (Aryaman et al., 2017b). Indeed,
assuming constant mitochondrial functionality, the study of
Johnston et al. (2012) predicts that a reduction in mtDNA
density results in lowered ATP concentrations, which results
in lowered transcription rate (Das Neves et al., 2010). These
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studies highlight the potential pathophysiological relevance of
maintaining mtDNA density homeostasis.
2.2. Intra-cellular Mutations in
Mitochondrial DNA Are a Source of
Genotypic Heterogeneity
2.2.1. MtDNA Mutation as a Source of Heterogeneity
Mitochondrial DNA is replicated and degraded, even in
non-proliferating tissues, which generates opportunities for
mtDNA mutations to arise and proliferate. Studies of mtDNA
mutation spectra in humans have suggested that point mutations
predominantly arise from replication errors (Kennedy et al.,
2013;Williams et al., 2013; Stewart and Larsson, 2014) as opposed
to oxidative damage (Kauppila and Stewart, 2015; Kauppila J.H.
et al., 2018), as is also the case for the “common” 4997 bp deletion
(Phillips et al., 2017).
2.2.2. Intra-cellular mtDNA Mutation as a Source of
Heterogeneity
Finite mutation rates during replication of mtDNA are expected
to give rise to a set of closely-related sequences which do
not all necessarily maximize fitness (Eigen and Schuster, 1977;
Nowak, 2006). Therefore, at the intra-cellular level, we expect
to observe mtDNA sequence diversity (see e.g., Jayaprakash
et al., 2015). Recent experimental work in primary cultures
of mouse neurons and astrocytes has shown this to be the
case (Morris et al., 2017). The authors found 3.9 ± 5.7
single nucleotide variations (SNVs) (± standard deviation) per
mitochondrion (Morris et al., 2017), with a mitochondrion
expected to contain around 5 molecules of mtDNA (Satoh
and Kuroiwa, 1991). The authors of this study found that
the distribution of allele frequencies was skewed toward 0%
heteroplasmy (Morris et al., 2017), suggesting the existence of
negative selection acting at the intra-cellular level (Birky et al.,
1983). However, several moderate/high impact mutations with
>90% heteroplasmy were also discovered (Morris et al., 2017),
suggesting that certain mutations are able to evade intra-cellular
selection and reach high levels of heteroplasmy. Further studies
are required to determine whether such high-heteroplasmy
variants become established through neutral drift, or whether a
positive selection mechanism exists; for example, it is possible
that heterogeneity in the intra-cellular environment establishes
intra-cellular niches which favor different mtDNA sequences.We
use the term “microheteroplasmy” to denote abundant ultra-low
heteroplasmic mutations within single cells (Figure 1Aii).
2.2.3. Pathological Consequences of
Microheteroplasmy
Whilst the pathological implications of microheteroplasmy
remain unclear, comparisons could be drawn to experiments
where a naturally occurring, but foreign, mtDNA haplotype is
introduced into a cell with which it has not co-evolved. Increasing
genetic distance amongst haplotypes has been shown to induce
tissue-specific selective pressures in mice (Burgstaller et al.,
2014), and heteroplasmy between otherwise healthy haplotypes
have been shown to induce fitness disadvantages (Acton et al.,
2007; Sharpley et al., 2012), as corroborated by bottom-up
mathematical modeling (Hoitzing et al., 2017a). Recent work has
shown that such fitness disadvantages may be mediated through
oxidative damage (Bagwan et al., 2018) (Figure 1Aiii).
2.3. Inter-cellular Mutations in
Mitochondrial DNA Are a Source of
Genotypic Heterogeneity
2.3.1. Cell-to-Cell Heterogeneity in Heteroplasmy
Increases Linearly With Time
Another consequence of the finite mutation rate of mtDNA,
and its stochastic turnover, is that mutations will occasionally
drift to very high level heteroplasmies simply by genetic drift
(Birky et al., 1983; Ewens, 2004), i.e., “macroheteroplasmy”
(Figure 1Aiii). Cell-to-cell heterogeneity in heteroplasmy
(heteroplasmy variance) therefore widens through time. Certain
deleterious mutations may therefore drift to high levels of
heteroplasmy and cause pathology (Rossignol et al., 2003) (see
Figure 2). Theoretical work predicts that heteroplasmy variance
increases approximately linearly, and increases with the rate
of mitophagic turnover of mtDNAs (Poovathingal et al., 2009;
Johnston and Jones, 2016), but decreases with total mtDNA copy
number with a non-linear dependence upon mean heteroplasmy
(Johnston and Jones, 2016). A linear increase in heteroplasmy
variance with time has recently been observed in mouse oocytes,
and over pup lifetimes (Burgstaller et al., 2018). Mathematical
modeling has suggested that increasing heteroplasmy variance
might increase the energetic cost of maintaining a tissue
(Hoitzing et al., 2017a).
2.3.2. Heteroplasmy Variance and Selective
Thresholds May Counter the Progressive Increase in
Mutant Load During Development
Increases in heteroplasmy variance can also purge mitochondrial
mutations when combined with selection, as observed between
generations in the human mitochondrial bottleneck (Johnston
et al., 2015; Burr et al., 2018; Floros et al., 2018). During
development, through a reduction of cellular mtDNA
copy number, heteroplasmy variance is increased. When
combined with a selective apoptotic threshold, whereby cells
above a heteroplasmic threshold undergo cell death, mean
heteroplasmy can be reduced. The mechanisms and timings of
the mitochondrial bottleneck are debated (Jenuth et al., 1996;
Cao et al., 2007; Cree et al., 2008; Wai et al., 2008); however,
stochastic modeling has shown that several proposals are
compatible with the induction of heteroplasmy variance through
a combination of random mtDNA partitioning at division and
passive turnover of mtDNA (Johnston et al., 2015; Johnston and
Jones, 2016; Hoitzing et al., 2017b).
2.3.3. Clonal Expansions of Mitochondrial Mutations
With Age Have Pathological Consequences
Mitochondrial mutations which survive the bottleneck can result
in severe congenital diseases (Schon et al., 2012), and accelerate
aging in the case of severe mutant loads in mice (Ross et al.,
2013). Under physiological conditions, mtDNA mutations are
also observed to accumulate with age across tissues in humans
(Khrapko et al., 1999; Taylor et al., 2003; Bender et al., 2006;
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FIGURE 2 | Factors influencing neutral genetic drift of mtDNA. Heteroplasmy (h, the fraction of a particular variant allele of mtDNA per cell) is not generally constant
between cells: it is a random variable and yields a distribution of cellular states. If the consensus and variant alleles experience the same instantaneous birth and death
rates per cell, then the heteroplasmy distribution is subject to “neutral drift.” Neutral drift is characterized by the increase in variance of the heteroplasmy distribution
with time. It is thought that when cells exceed a particular threshold heteroplasmy, a pathological phenotype may be expressed (red bars). Therefore, the number of
pathological cells may increase with heteroplasmy variance. Mathematical modeling has shown that the rate of increase of heteroplasmy variance V(h) increases with
mitophagy rate, as higher turnover provides more opportunities for replication of either allele and cause a change in h. V(h) changes with copy number, since large
populations are more robust to fluctuations. For a given spread of heteroplasmies, V(h) changes at a maximal rate when mean heteroplasmy is 0.5, and diminishes as
one allele dominates over the other. It has recently been shown that mitochondrial network fragmentation can rescale the turnover rate: larger fragmentation results in
V(h) increasing faster with time—as more mitochondria are susceptible to mitophagy—independently of the absolute fusion-fission rates (see Equation 1).
Kraytsberg et al., 2006; Li et al., 2015; Kauppila et al., 2017).
Certain cases of mutant accumulation (or “clonal expansion”)
may be explained by neutral drift, for instance partitioning
noise in highly proliferative colonic crypt cells can result in
highly mutated crypts (Taylor et al., 2003). However, positive
selection through replicative advantage (Samuels et al., 2013)
and tissue-specific niches (Avital et al., 2012; Li et al., 2015;
Ahier et al., 2018) can also influence heteroplasmy dynamics.
The extent to which mtDNA mutations present at birth, as
opposed to somatic mutation post-development, contribute to
healthy aging remains open. Bulk heteroplasmy measurements
in monozygotic twins have shown that inherited mutations can
contribute mitochondrial mutations, including heteroplasmic
mutations with a low mutant load (Avital et al., 2012). The vast
amount of DNA replication during development itself is also
likely to seed and expand a number of potentially pathological
mtDNA mutations (Hahn and Zuryn, 2018), as is thought
to be the case in the nuclear genome (Keogh et al., 2018).
Mitochondrial mutations which arise and focally expand post-
development in skeletal muscle contribute to pathological age-
related loss in muscle mass (Khrapko et al., 1999; Aiken et al.,
2002; Bua et al., 2006; Vincent et al., 2018). In the case of
human muscle fibers of healthy individuals, the number of
fibers exhibiting electron transport chain (ETC) abnormalities
increases from approximately 6% at age 49–31% at age 92 (Bua
et al., 2006). Serial sections through laser-captured single skeletal
muscle fibers showed that heteroplasmy in mtDNA deletions
may exceed 90% (Bua et al., 2006). Deletion mutations have
been associated with local fiber atrophy and breakage in mice
(Wanagat et al., 2001; Khrapko and Vijg, 2009) and rhesus
monkeys (Aiken et al., 2002) (although the causative role of
mtDNAmutations in aging for shorter-lived animals is contested;
Vermulst et al., 2007; Kauppila T.E. et al., 2018; Lakshmanan
et al., 2018). It is noteworthy that mitochondrial dysfunction
in a particular tissue is able to induce stress responses in distal
tissues through the mitochondrial unfolded protein response
(Zhao et al., 2002; Durieux et al., 2011; Zhang et al., 2018) and
other hormonal signaling pathways (Tyynismaa et al., 2010; Khan
et al., 2017), suggesting potential organism-wide consequences
of focal mitochondrial mutations. The development of novel,
quantitative, dyes for electron transport chain (ETC) deficiency
may allow more refined measurements of the causes of deletion
proliferation in somatic tissues in the future (Simard et al., 2018;
Vincent and Picard, 2018).
2.3.4. Inter-cellular Mitochondrial Exchange as a
Physiological Means to Slow Heteroplasmy Variance
Mitochondria have been observed to be transferred between cells
(Spees et al., 2006; Torralba et al., 2016), and the intercellular
transfer of other organelles has also been observed (Rustom
et al., 2004). Several mechanisms by which mitochondrial
transfer is achieved are known, including tunneling nanotubes
(Koyanagi et al., 2005) and microvesicles (Phinney et al.,
2015), amongst others (Torralba et al., 2016). Intercellular
mitochondrial exchange has largely been understood through
in vitro experiments (Spees et al., 2006; Jayaprakash et al.,
2015; Berridge et al., 2016a); however, recent developments
have shown the effect to also be relevant in vivo (e.g., Islam
et al., 2012; Ahmad et al., 2014; Berridge et al., 2016a). For
instance, Islam et al. (2012) have shown that mousemesenchymal
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stem cells (MSCs) are able to release microvesicles containing
mitochondria, and protect against sepsis-induced acute lung
injury in mice. Recent evidence from xenograft mouse models
have also shown that mtDNA can be transferred between cells
via exosomes, mediating an escape from dormancy in therapy-
resistant breast cancer cells (Sansone et al., 2017). Furthermore,
astrocytes have been found to donate mitochondria to neurons
after stroke (Hayakawa et al., 2016), although interpretations of
these data exist which do not require mitochondrial exchange
(Berridge et al., 2016b). In terms of mitochondrial genetic
dynamics, intercellular exchange of mtDNA appears to slow
down heteroplasmic drift (Jayaprakash et al., 2015) and thereby
reduce cell-to-cell mitochondrial genetic heterogeneity. It is
possible that inter-cellular exchange of mitochondria, and
mitochondrial DNA, is an evolved mechanism to ameliorate
heteroplasmy variance and therefore the build-up of cells with
pathological levels of heteroplasmy. Although the existence of
inter-cellular mitochondrial exchange has now been established,
the extent and dynamics of mtDNA transfer remain incompletely
understood.
2.3.5. Gene Therapy as a Means to Therapeutically
Control Heteroplasmy Distributions
Gene-editing technologies targeted at the mitochondrial genome
are under development (Bacman et al., 2013, 2018; Gammage
et al., 2014, 2018; Reddy et al., 2015; Pereira et al., 2018). Such
technologies sequence-specifically bind and cleave mitochondrial
DNA, which is subsequently degraded rapidly (Peeva et al.,
2018). Mathematical modeling of mitochondrially-targeted gene
therapies predicts that tissues with high mean heteroplasmy
and large heteroplasmy variance are generally more difficult to
treat (Hoitzing et al., 2017a); there is therefore a close link
between these promising therapeutic technologies and inter-
cellular heterogeneity in heteroplasmy.
3. NON-GENETIC SOURCES OF
MITOCHONDRIAL HETEROGENEITY
Apart from the mitochondrial genome, there are many non-
genetic properties of mitochondria which can vary. One such
property which is particularly clear is ETC protein structure,
which is influenced by sequence heterogeneity in mtDNA
(Figure 1Bi)—this being a potentially important source of both
intra- and inter-cellular variability. Other non-genetic differences
in mitochondria can include mitochondrial membrane
composition/structure, ion content, membrane potential
and network structure. Intra-cellular spatial heterogeneity
through the existence of sub-cellular mitochondrial niches
(Palmer et al., 1977; McKenna et al., 2000; Benador et al., 2018),
e.g., perinuclear vs. peripheral locations, has been highlighted as
an important axis of mitochondrial heterogeneity by previous
authors (see Wikstrom et al., 2009). Below, we discuss several
other aspects in which non-genetic attributes of mitochondria
may vary, and the potential pathological consequences of
such variation. We also draw attention to how non-genetic
heterogeneity may be driven by, or drive, genetic heterogeneity
through genotype-phenotype links.
3.1. Stoichiometric and Structural
Heterogeneity in the Inner Mitochondrial
Membrane as a Potential Amplifier of the
Genotype-Phenotype Link
3.1.1. MtDNA Genotype as a Driver of IMM Phenotype
The inner mitochondrial membrane (IMM) is heterogeneous in
both its composition and its topology. The connection between
the IMM and the mitochondrial genotype is particularly relevant
since mitochondrial DNA is situated in the mitochondrial matrix
and in close proximity to the IMM (Brown et al., 2011).
Consequently, one might expect mtDNAs to affect their local
respiratory units more than distal mtDNAs (Busch et al., 2014),
thus allowing greater control of respiration at a local level (Allen,
1993, 2003; Lane, 2011). Below we discuss aspects of how IMM
physiology may generate mitochondrial heterogeneity, and how
cardiolipin may act as a sensor of the mitochondrial genotype.
We discuss how cardiolipin reacts to differences in reactive
oxygen species (ROS) production and pH, and may amplify the
mitochondrial phenotype through supercomplex formation and
cristal structure.
3.1.2. Mitochondrial Supercomplex Stoichiometry as
an Axis of IMM Heterogeneity
The stoichiometry of respiratory units within the IMM can vary,
since respiratory units organize into supramolecular structures
termed supercomplexes (Schägger and Pfeiffer, 2000; Enríquez,
2016) (Figure 1Biii). A variety of supercomplex stoichiometries
exist in mammalian cells (Schägger and Pfeiffer, 2000; Schäfer
et al., 2006) as well as free resipriatory subunits (Schägger
and Pfeiffer, 2000). The “plasticity model” has therefore been
suggested (Acín-Pérez et al., 2008), whereby a landscape
of combinations between respiratory complexes coexist.
Dysfunction in the assembly of mitochondrial supercomplexes in
mice results in decreased muscle activity and heat production in
the cold due to reduced CIV activity (Ikeda et al., 2013), showing
that supercomplex assembly is required for fully-functional
respiration. Consequently, dysfunction in supercomplex
assembly could affect mitochondrial quality control pathways
and influence the mitochondrial genotype.
3.1.3. Cristal Structure as an Axis of IMM
Heterogeneity
The topologies of mitochondrial membranes are heterogeneous
(Mannella, 2006; Enríquez, 2016), and this heterogeneity may
potentially be driven by mitochondrial genetic heterogeneity
(see above), as we will discuss at the end of this subsection.
ATP-synthase forms dimers in the IMM which often arrange
into micron-scale rows, which are associated with high local
curvature to form mitochondrial cristae (Strauss et al., 2008;
Davies et al., 2012). Recent work has suggested that the
mitochondrial fusion protein OPA1 stabilizes ATP synthase
oligomers by modulating cristal shape (Quintana-Cabrera et al.,
2018). Crista membranes show an enrichment of respiratory
complexes relative to the inner boundary membrane (Gilkerson
et al., 2003; Vogel et al., 2006), and it has been suggested
that cristae exist to increase the packing density of respiratory
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units (Rieger et al., 2014). Individual cristae are morphologically
heterogeneous in mammalian cells (Frey and Mannella, 2000),
and can be modulated in response to altered metabolic demands
(Eisner et al., 2018): cristae become narrower in mammalian
cells in response to starvation (Patten et al., 2014), suggesting
that cristal shape influences respiratory efficiency, perhaps by
modulating local substrate concentrations (Mannella et al.,
2001) (Figure 1Bii). Remodeling of mitochondrial morphology
occurs during cell death (Scorrano et al., 2002; Yamaguchi
et al., 2008), whereby supercomplexes and dimers of ATP
synthase disassemble and cristal structure becomes disorganized
(Cogliati et al., 2016), allowing the release of cytochrome c (an
electron carrier of the ETC) to trigger the intrinsic cell death
pathway (Taylor et al., 2008) (although the importance of crista
remodeling for cytochrome c release has been questioned; Tam
et al., 2010). The intimate connection between mitochondrial
physiology and cell death provides insight into the recent
observation that mitochondrial heterogeneity can partially
explain variability in chemotherapeutic resistance in HeLa cells
(Márquez-Jurado et al., 2018).
3.1.4. Cardiolipin Is Necessary for Supercomplex and
Crista Stabilization
Cardiolipin is a phospholipid found in the IMM, and stabilizes
both supercomplexes and cristal structure. When exposed to a
pH gradient, cardiolipin-containing lipid vesicles spontaneously
form crista-like membrane invaginations (Khalifat et al., 2008,
2011), thus providing a potential connection between respiratory
activity, which is influenced by mtDNA genotype, and cristal
shape. Furthermore, flies with deficient cardiolipin levels show
reduced ATP synthase abundance in high-curvature regions of
cristae, resulting in disorganized cristae, cardiac insufficiency,
motor weakness and early death (Acehan et al., 2011). In yeast,
cardiolipin has been shown to be necessary for supercomplex
stabilization (Zhang et al., 2002; Pfeiffer et al., 2003). Indeed,
patients with Barth syndrome who are deficient in cardiolipin
due to a mutation in the tafazzin gene show both aberrant
crista formation (Acehan et al., 2011) and reduced supercomplex
formation (McKenzie et al., 2006).
3.1.5. Cardiolipin as a Potential Amplifier of mtDNA
Heterogeneity Through Alterations in pH and ROS
Generation
Cardiolipin is particularly susceptible to damage by ROS. In
isolated bovine mitochondria, ROS exposure resulted in loss
of CI activity, but exogenously added cardiolipin could restore
CI activity (Paradies et al., 2002). It has recently been shown
that a mitochondrially-targeted antioxidant (MitoQ) is able to
increase cardiolipin expression and content in liver mitochondria
of rats fed on a high-fat diet, resulting in increased mitochondrial
functionality and ATP synthase activity (Fouret et al., 2015).
Together, this suggests that mitochondrial dysfunction, which
alters pH gradients across the IMM and ROS production, can
cause cristae to become disorganized and affect supercomplex
assembly via cardiolipin, potentially resulting in further loss of
mitochondrial efficiency and ROS production. It is possible that
heterogeneity in pH and ROS production, for instance through
mtDNAmutation heterogeneity (Lane, 2011), could be amplified
through such mechanisms and thus strengthen the genotype-
phenotype link between mtDNA and their local respiratory
complexes.
3.2. Mitochondrial Membrane Potential
Heterogeneity, Mitochondrial Networks,
and Mitochondrial Genotype
3.2.1. Inter-cellular Mitochondrial Membrane
Potential Heterogeneity as a Predictor of
Cell-Physiological Heterogeneity
The inner membrane potential (19) is an indicator of
mitochondrial functionality, generated by the ETC, which drives
the synthesis of ATP by ATP-synthase. Mitochondrial output is
highly sensitive to 19 : a 14 mV change in 19 corresponds
to a 10-fold change in the maximum ATP/ADP ratio (Nicholls,
2004), where 19 typically ranges between 150 and 180 mV
(Perry et al., 2011). Quantification of the absolute value of
19 in millivolts at a single-cell level through fluorescence
probes (Perry et al., 2011) is possible but technically challenging,
requiring deconvolution from other confounding factors such
as fluctuations in plasma membrane potential, the matrix:
cell volume ratio, dye activity and binding affinity in the
matrix/cytosol, and spectral changes resulting from binding
(Gerencser et al., 2012, 2016). Many studies involving 19
measurements through Nernstian dyes neglect these possible
confounding variables and assume differences in fluorescence
are always directly attributable to differences in 19 , so some
caution is required. With these caveats in mind, measurements
of mitochondrial mass scaled by 19 has been shown to explain
much of the variation in transcript elongation rate (Das Neves
et al., 2010; Johnston et al., 2012) and protein noise (Guantes
et al., 2015), as well as predicting phenomena such as cell cycle
duration (Johnston et al., 2012) and chemotherapeutic resistance
(Márquez-Jurado et al., 2018) in mammalian cells (Figure 1Bvi).
3.2.2. Calcium and pH Transients as Determinants of
Intra-cellular 19 Fluctuations
In addition to inter-cellular 19 heterogeneity, individual
mitochondria have been shown to undergo transient
depolarization/repolarization cycles, termed “flickers” in animals
(Duchen et al., 1998; O’Reilly et al., 2003) or “pulses” in plants
(Schwarzländer et al., 2012) (Figure 1Biv). In freshly dissociated
smooth muscle cells, flickers range from <10 mV to >100 mV,
typically lasting on the order of seconds (O’Reilly et al., 2003). It
has been proposed that mitochondrial flickers are regulated by
various mechanisms, including mitochondrial inner membrane
fusion (Santo-Domingo et al., 2013), Ca2+ influx (Duchen et al.,
1998; Jacobson and Duchen, 2002), and transient opening of the
mitochondrial permeability transition pore (mPTP) (Hüser and
Blatter, 1999; Jacobson and Duchen, 2002). The mPTP is thought
to be a non-selective mitochondrial channel that induces cell
death when open for prolonged periods (Bernardi et al., 2006).
In rat myocytes, opening of the mPTP through pharmacological
intervention has been found to correlate with the frequency
of transients in circularly permuted yellow fluorescent protein
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(cpYFP) fluorescence (Wang et al., 2008). cpYFP has been shown
to be sensitive to pH (Schwarzländer et al., 2011, 2014; Santo-
Domingo et al., 2013), therefore transient cpYFP fluorescence
corresponds to transient alkalinization of the mitochondrial
matrix (i.e., an increase in pH gradient across the IMM). Since
one would expect a reduction in pH gradient if the mPTP
were behaving in a non-selective mode, transient alkalinization
potentially implies an ion-selective mode of the mPTP. The
coincidence of an increase in pH gradient, and loss of membrane
potential, indicates a redistribution of the proton motive force,
which has pH and electrical contributions (Nicholls, 2004). This
redistribution may be mediated by selective ion movement.
Flickers have been shown to exist in vivo in mouse astrocytes,
and are enhanced by both neuronal activity and oxidative shifts
(Agarwal et al., 2017), which is consistent with previous in vivo
observations in mice (Breckwoldt et al., 2014, 2016). Although
no clear consensus exists on the mechanisms of transient
mitochondrial depolarization/alkalinization cycles, such cycles
appear to be a likely means of regulating metabolic rate, and
perhaps ROS production, at the single mitochondrion level.
3.2.3. Mitochondrial Membrane Potential Influences
Mitochondrial Genotype Through Quality Control
The canonical means by which mitochondrial membrane
potential feeds back into the genetic state is through mitophagy
and mitochondrial network dynamics (Twig et al., 2008).
Mitochondria are not static organelles but undergo dynamic
fusion and fission, the purpose of which is incompletely
understood (Hoitzing et al., 2015). In rat pancreas cells,
it has been shown that fission often results in a daughter
mitochondrion which has a lower 19 than its sister (Twig
et al., 2008). These depolarized mitochondria have a lowered
propensity for fusion, and are more likely to be degraded
(Twig et al., 2008). Selective fusion, when combined with
non-selective mitophagy, is sufficient to preferentially degrade
depolarized/damaged mitochondria (Hoitzing et al., 2015;
Aryaman et al., 2018), although the selective strength of
mitophagy itself is not yet fully understood. The extent to
which mitochondria which are degraded via selective/non-
selective forms of mitophagy possess mitochondrial genomes
which are perturbed from the consensus sequence also
remains incompletely understood (Lemasters, 2014). However, if
depolarized mitochondria are more likely to be perturbed from
the consensus mitochondrial sequence, mitochondrial quality
control mechanisms would exert a negative selective pressure
against variant alleles. Indeed, negative selection pressures have
been observed in human tissues (Li et al., 2010, 2015; Avital et al.,
2012; Ye et al., 2014) and at the intracellular level in mice (Morris
et al., 2017), whichmay be due to a combination of mitochondrial
networks and mitophagy.
3.2.4. If Quality Control Is Weak, Mitochondrial
Network Fragmentation Slows Heteroplasmy
Variance Through a Rescaling of Time
The existence of mitochondrial diseases (Schon et al., 2012),
the ubiquity of heteroplasmy (Payne et al., 2012; Morris et al.,
2017), and the accumulation of heteroplasmy with age (Li et al.,
2015), suggest that mitochondrial quality control may be weak
for certain sequences. Building on insights from previous work
(Mouli et al., 2009; Tam et al., 2013, 2015; Johnston and Jones,
2016), recent mathematical modeling (Aryaman et al., 2018)
suggests that, if quality control is weak, heteroplasmy variance
V(h) follows the equation
V(h) ≈ fs
2µt
n
h0(1− h0) (1)
where t is time, fs is the fraction of unfused mitochondria,
µ is the mitophagy rate, n is copy number and h0 is the
initial heteroplasmy, which is equivalent to mean heteroplasmy
under neutral drift (see Figure 2). This equation arises through
the assumption that larger mitochondrial fragments are at a
reduced susceptibility to degradation, as is observed empirically
(Twig et al., 2008). As a consequence, total mitochondrial
turnover is modulated by the fraction of unfused mitochondria,
independently of the absolute magnitude of fusion-fission
rates (Aryaman et al., 2018). Since heteroplasmy variance is
proportional to mitochondrial turnover through mitophagy
(Johnston and Jones, 2016), mitochondrial fragmentation may
therefore modulate the rate of accumulation of pathologically
mutated cells in a tissue, independently of selective effects
(Aryaman et al., 2018) (Figure 1Bv). Mitochondrial network
fragmentation may also slow de novo mutation (Aryaman et al.,
2018) through a rescaling of mitochondrial turnover (which is
known tomodulate the de novomutation rate; Poovathingal et al.,
2009). As a consequence, promoting mitochondrial fusion earlier
in life, when mean heteroplasmy is low, may delay the rate of
accumulation of cells with pathological levels of mutated mtDNA
(Aryaman et al., 2018), which may have implications for healthy
aging.
3.3. Mitochondrial Complementation May
Dampen the Genotype-Phenotype Link but
Its Extent Is Incompletely Understood
3.3.1. Mitochondrial Complementation Is Thought to
Partially Buffer Genotype-Phenotype Links via the
Threshold Effect
Mitochondrial “complementation” consists of mitochondria
sharing their contents through fusion-fission events, and
potentially complementing each others’ genetic defects (Hayashi
et al., 1994; Yoneda et al., 1994; Enrıquez et al., 2000; Ono
et al., 2001). This is supported by experiments involving
photoactivatable fluorescent proteins which show that intra-
mitochondrial contents mix over time (Twig et al., 2008; Wilkens
et al., 2013). Inhibition of fusion and fission have also been
shown to induce heterogeneity in the distribution of aged
mitochondrial proteins (Ferree et al., 2013). Beyond depending
on fission and fusion rates, and the degree of mitochondrial
mobility, the strength of complementation is closely linked to
the diffusivity of the mitochondrial matrix: if the matrix is a
high-diffusivity environment then gene products are expected
to be promiscuous within the matrix and not remain local to
their parental mtDNA. Therefore, in cells heteroplasmic between
wild-type and a pathological mutant, healthy versions of any
particular transcript would be found in the matrix. The idea
of complementation is also closely linked to the mitochondrial
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threshold effect (Rossignol et al., 2003; Stewart and Chinnery,
2015; Aryaman et al., 2017b), whereby complementation effects
allow cells to withstand high levels of mutant load (60–90%,
Chomyn et al., 1992; Miyabayashi et al., 1992; Rossignol et al.,
2003) before displaying a respiratory defect.
3.3.2. Mitochondrial Complementation Remains
Incompletely Understood
Much of the progress in understanding mitochondrial
complementation derives from cell fusion studies where
cells harboring different mtDNA mutations are fused, and
mitochondrial functionality recovers through sharing of
transcription products (Ono et al., 2001; Gilkerson et al., 2008;
Yang et al., 2015). Such experiments highlighted physiological
subtleties which remain incompletely understood. For instance,
the experiment of Ono et al. (2001) between cells harboring two
different mt-tRNA mutations required an adaptive period of
10–14 days before respiratory activity was restored—the reason
for this was not fully understood. Furthermore, cell fusion
studies between cells harboring partially-functional (3271T>C)
and completely dysfunctional (3243A>G) mitochondrial tRNA-
Leu mutations resulted in a sigmoidal relationship between
heteroplasmy and COX-activity, whereas a linear relationship
was observed for simple co-culture between the two cell types
(Ono et al., 2004), which again lacks a complete explanation. In
contrast to the experiment of Ono et al. (2001), an experiment
by Gilkerson et al. (2008) between two non-overlapping
mitochondrial deletions showed recovery of MTCO2 protein
production on a relatively fast timescale (4 days). Furthermore,
Gilkerson et al. (2008) found that fused cells cycled between
heteroplasmic and homoplasmic states during long-term
culture, despite being on a medium which mildly selected
for mitochondrial function (but still allowed ATP production
through glycolysis). Yet, a straightforward interpretation of
complementation would suggest that heteroplasmic states would
show maximal fitness. This effect was originally explained as
a tension between a neutral genetic drift effect, deriving from
the assumption that nucleoids possess several mtDNAs (Jacobs
et al., 2000), and selective pressure for heteroplasmy (Gilkerson
et al., 2008). However super-resolution microscopy studies have
revealed that nucleoids harbor only 1–2 mtDNAs per nucleoid
(Kukat et al., 2011, 2015). It is possible that large drift rates
could be explained by the passive partitioning of very large
clusters of genetically homogeneous mtDNA at cell division.
Furthermore, active asymmetric apportioning of damaged
or aged mitochondria has been observed in yeast (McFaline-
Figueroa et al., 2011) and stem cells (Katajisto et al., 2015)
(which has been shown to influence cellular fate decisions in
immune cells; Adams et al., 2016); therefore, active mechanisms
of asymmetric apportioning of mitochondrial genomes may also
exist. Cycles between heteroplasmy and homoplasmy highlight
an area for future experimental and theoretical investigation.
3.3.3. Restricted Diffusion in the IMM May Inhibit
Complementation
Experiments by Wilkens et al. (2013) fused HeLa cells with
mitochondrially-targetted fluorescent proteins of differing colors
to investigate the extent of mitochondrial diffusivity. The
authors found that, through cycles of mitochondrial fusion
and fission, IMM proteins appear to experience slow diffusion
relative to the outer mitochondrial membrane, and retain cristal
structure (Wilkens et al., 2013). Consequently, complementation
may be diminished since gene products may remain local
to their parental mtDNA (Busch et al., 2014), allowing local
control of respiration (Allen, 1993, 2003; Lane, 2011). This is
supported by the observation that mitochondrial transcripts are
particularly concentrated around mtDNA (Ozawa et al., 2007).
Mathematical modeling of progressive increases in heteroplasmy
of the pathological 3243A>G mutation is compatible with
the interpretation that tRNAs are enriched in the vicinity of
their local mtDNA, and that mutated mtDNAs experience a
local depletion of ATP resulting in a transcriptional defect
(Picard et al., 2014; Aryaman et al., 2017b). Hence, restricted
complementation and local phenotype-genotype links appear to
be explanatory.
4. DISCUSSION
Mitochondrial heterogeneity can occur at various scales. In this
review, we have focussed on heterogeneity in the mitochondrial
population within a cell (e.g., microheteroplasmy Morris
et al., 2017) and inter-cellular heterogeneity of aggregate per-
mitochondrion observables (e.g., variation in inter-cellular
membrane potential; DasNeves et al., 2010; Johnston et al., 2012).
Heterogeneity also exists at larger scales, for instance between
organs of a particular individual (e.g., tissue-specific genetic
selective pressures upon mtDNA; Burgstaller et al., 2014; Li et al.,
2015; Ahier et al., 2018), and heterogeneity between individuals
(e.g., variation in the consensus sequence between individuals of
different mitochondrial haplotypes; Wallace and Chalkia, 2013).
We have pointed out the genetic and non-genetic sources of such
intra- and inter- cellular mitochondrial heterogeneity, as well as
its pathological significance.
We note that mitochondrial epigenetic modification is also
a potential layer of non-genetic mitochondrial heterogeneity
(Figure 1Bvii). Mitochondrial DNA can undergo methylation
(van der Wijst and Rots, 2015); although its physiological
impact is still being unraveled, it has been suggested that
methylationmay regulate mtDNA gene expression (van derWijst
et al., 2017). Furthermore, whilst oxidative damage to mtDNA
nucleotides have classically been known for their potential
role in mutagenesis, it has been proposed that the formation
of 8-OHdG, which is a ROS-modified version of guanine,
induces mitochondrial mutations at the transcriptional level
(Nakanishi et al., 2012) and may be responsible for premature
aging phenotypes in mice bred to rapidly accumulate mtDNA
mutations (Trifunovic et al., 2004; Safdar et al., 2011, 2016).
Post-transcriptional modifications of mitochondrial transcripts
(Bar-Yaacov et al., 2013), potentially modulated by heterogeneity
in the sequence of nuclear DNA (Hodgkinson et al., 2014),
are also possible sources of mitochondrial heterogeneity,
which potentially constitute a rich and fascinating avenue for
future research. Further downstream sources of mitochondrial
heterogeneity, such as translation errors, have also been shown
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to have physiological consequences in budding yeast (Suhm
et al., 2018). The age-related functional decline of mitochondria
in shorter-lived animals (Itsara et al., 2014; Brandt et al.,
2017) might not be explained directly by mtDNA mutations
(Vermulst et al., 2007; Lakshmanan et al., 2018) (see also
recent, contrasting, results in Drosophila; Kauppila T.E. et al.,
2018; Samstag et al., 2018). However, the mechanisms described
above which are downstream of mtDNA mutation, but are
nevertheless constrained by mtDNA, may still be able to explain
this functional decline.
We have also discussed how genotype-phenotype links
provide feedback between genetic and non-genetic states. The
mitochondrial genotype may drive the phenotype through e.g.,
the genotype influencing ROS formation and pH gradients. This
may, in turn, affect cardiolipin, supercomplex formation and
cristal structure, which ultimately affect respiratory capacity. On
the other hand, the mitochondrial phenotype may influence
the genotype through e.g., the mitochondrial network and
mitophagy. This may, in turn, modulate the mean and variance
of the heteroplasmy distribution.
The interdependence between genetic and non-genetic
sources of mitochondrial heterogeneity means that it is difficult
to state which sources of mitochondrial heterogeneity are the
most important in general. However, one may argue that genetic
variability occurs on a slower timescale and may drive slowly-
varying aspects of non-genetic mitochondrial heterogeneity.
Slowly-varying aspects of mitochondrial heterogeneity may
be especially important in explaining heterogeneous health
outcomes during healthy aging (Lowsky et al., 2013; Sun
et al., 2016; Kauppila et al., 2017). Therefore, understanding
the dynamics of mitochondrial genetics through time has
the potential to be particularly explanatory for age-related
mitochondrial dysfunction. There exist various competing
theoretical models which have the potential to describe
mitochondrial genetic dynamics (Chinnery and Samuels, 1999;
Wonnapinij et al., 2008; Poovathingal et al., 2009; Johnston
and Jones, 2016; Aryaman et al., 2018); future interdisciplinary
studies are required to constrain which of these models
are statistically best able to describe experimental data (see
e.g., Johnston et al., 2015 for an example of how statistical
inference can constrain different theoretical explanations of the
mitochondrial bottleneck).
In order to deepen our understanding of mitochondrial
genetics, it is important for experimental studies to shift away
from heteroplasmy measurement in bulk cellular samples,
and toward single-cell studies. In bulk measurements,
there is no way to determine whether individual cells
are homoplasmic or heteroplasmic: this has important
consequences for development and mitochondrial inheritance
(Johnston and Jones, 2015; Johnston et al., 2015). Furthermore,
in the context of variations in mtDNA copy number between
experimental conditions, inferences about differences in
heteroplasmy in tissue homogenate can be erroneous and
apparently display selective effects where there are in fact none
(Hoitzing et al., 2017a). Such difficulties may be circumvented
when heteroplasmy is measured at the single-cell level.
We have highlighted several other important outstanding
questions in the field of mitochondrial heterogeneity:
• What explains the apparent ubiquity of mtDNA copy number
density homeostasis, despite mtDNA density being a potential
axis of energetic control?
• What is the extent, and physiological importance, of
microheteroplasmy (Figure 1Aii)?
• To what extent do inherited mtDNA mutations, vs. somatic
mtDNA mutations, contribute to healthy aging?
• To what extent does mitochondrial exchange affect
heteroplasmy dynamics?
• To what extent can non-genetic mitochondrial heterogeneity
in factors such as pH, ROS production, and cristae structure
be explained by genetic mitochondrial heterogeneity?
• Under what circumstances, and to what extent, is mitophagy
selective under physiological conditions?
• To what extent are mtDNAs asymmetrically partitioned
amongst proliferating cells in vivo?
• To what extent may mtDNAs complement each others genetic
defects through sharing of gene products?
The richness in sources of mitochondrial heterogeneity, as well
as the growing appreciation of its pathophysiological importance,
will likely provide future insight into the determinants of cellular
heterogeneity and its associated pathologies.
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